CytomX Therapeutics Ownership | Who Owns CytomX Therapeutics?
CytomX Therapeutics Ownership Summary
CytomX Therapeutics is owned by 16.90% institutional investors, 0.59% insiders, and 82.51% retail investors. Fmr is the largest institutional shareholder, holding 18.78% of CTMX shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.64% of its assets in CytomX Therapeutics shares.
CTMX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | CytomX Therapeutics | 16.90% | 0.59% | 82.51% |
| Sector | Healthcare Stocks | 35.64% | 12.08% | 52.28% |
| Industry | Biotech Stocks | 35.43% | 12.01% | 52.56% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 31.96M | 18.78% | $150.19M |
| Kynam capital management, lp | 15.01M | 8.82% | $70.56M |
| Tang capital management | 11.07M | 8.57% | $35.30M |
| Perceptive advisors | 10.10M | 5.93% | $47.46M |
| Vr adviser | 9.98M | 5.87% | $46.92M |
| Vanguard group | 8.48M | 5.14% | $36.11M |
| Point72 asset management | 7.88M | 4.63% | $37.01M |
| State street | 5.66M | 3.33% | $26.62M |
| Citadel advisors | 5.41M | 3.18% | $25.41M |
| Adar1 capital management | 4.05M | 3.13% | $12.90M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kynam capital management, lp | 15.01M | 4.35% | $70.56M |
| Vr adviser | 9.98M | 1.75% | $46.92M |
| Velan capital investment management lp | 540.00K | 1.59% | $2.54M |
| Nextech invest | 4.45M | 1.47% | $20.91M |
| Tang capital management | 11.07M | 1.36% | $35.30M |
| Exome asset management | 521.47K | 1.27% | $2.45M |
| Adar1 capital management | 4.05M | 1.21% | $12.90M |
| Perceptive advisors | 10.10M | 0.93% | $47.46M |
| Schulhoff | 477.55K | 0.92% | $2.24M |
| Patient square capital lp | 1.09M | 0.91% | $5.10M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 31.96M | 0.01% | 7.27M |
| Kynam capital management, lp | 15.01M | 4.35% | 6.05M |
| Citadel advisors | 5.41M | 0.00% | 5.06M |
| Nextech invest | 4.45M | 1.47% | 4.45M |
| Wellington management group llp | 3.58M | 0.00% | 3.58M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Commodore capital lp | - | - | -7.69M |
| Franklin resources | - | - | -5.77M |
| Vr adviser | 9.98M | 1.75% | -5.58M |
| Bvf inc/il | - | - | -5.23M |
| Fairmount funds management | - | - | -3.90M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Nextech invest | 4.45M | 1.47% | 4.45M | $20.91M |
| Wellington management group llp | 3.58M | 0.00% | 3.58M | $16.84M |
| Siren | 3.46M | 0.45% | 3.46M | $16.25M |
| Gilder gagnon howe | 1.12M | 0.06% | 1.12M | $5.27M |
| Vanguard fiduciary trust | 1.10M | 0.00% | 1.10M | $5.18M |
Sold Out
| Holder | Change |
|---|---|
| Innealta capital | -2.00 |
| Old point trust & financial services n a | -250.00 |
| Raleigh capital management | -250.00 |
| Bell investment advisors | -388.00 |
| Federated hermes | -398.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 60 | -53.85% | 23,309,564 | -83.82% | 16 | 0.22% | 40 | -48.05% | 11 | -59.26% |
| Dec 31, 2025 | 70 | -37.50% | 44,567,168 | -67.59% | 27 | 0.39% | 42 | -32.26% | 16 | -38.46% |
| Sep 30, 2025 | 36 | -59.09% | 16,872,803 | -87.34% | 13 | 0.12% | 20 | -64.91% | 7 | -58.82% |
| Jun 30, 2025 | 88 | 35.38% | 133,304,249 | 195.10% | 153 | 5.69% | 57 | 128.00% | 16 | -36.00% |
| Mar 31, 2025 | 66 | -7.04% | 45,273,213 | -3.09% | 51 | 1.72% | 26 | -25.71% | 25 | 19.05% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 7.93M | 3.64% | -176.70K |
| Vanguard US Total Market Shares ETF | 2.46M | 3.07% | - |
| Vanguard Total Stock Mkt Idx Inv | 6.23M | 2.86% | -301.40K |
| Fidelity Select Health Care | 5.00M | 2.30% | - |
| iShares Russell 2000 ETF | 4.64M | 2.13% | 27.52K |
| Fidelity Small Cap Growth | 3.97M | 1.82% | - |
| Franklin Biotechnology Discv A(acc)USD | 2.92M | 1.77% | -800.28K |
| Fidelity Select Biotechnology | 2.77M | 1.27% | - |
| Strategic Advisers Fidelity US TtlStk | 2.65M | 1.22% | 7.29K |
| Fidelity Advisor Health Care I | 2.50M | 1.15% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Ogden Christopher | Chief Financial Officer | Sell | $4.95K |
| Mar 17, 2026 | Chu Yu-Waye | Chief Medical Officer | Sell | $136.68K |
| Mar 17, 2026 | McCarthy Sean A. | CEO | Sell | $764.14K |
| Mar 17, 2026 | BELVIN MARCIA | SVP, Chief Scientific Officer | Sell | $202.27K |
| Mar 17, 2026 | Ogden Christopher | Chief Financial Officer | Sell | $124.11K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 1 |
| 2026 Q1 | - | 4 |
| 2025 Q4 | - | 1 |
| 2025 Q3 | - | - |
| 2025 Q2 | - | 4 |
CTMX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools